Patents Assigned to Angel Pharmaceutical Co., Ltd.
  • Compounds and methods for modulating Bruton's Tyrosine Kinase
    Patent number: 11306099
    Abstract: Provided herein, inter alia, are compounds and methods for modulating Bruton's Tyrosine Kinase.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: April 19, 2022
    Assignee: Angel Pharmaceutical Co., Ltd.
    Inventors: Ryan Hudson, Anne-Marie Beausoleil, Richard A. Miller, Erik Verner